{
    "2019-05-22": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-22",
                "original_text": "Congo wants more use of Merck vaccine rather than J&J newcomer - minister",
                "features": {
                    "keywords": [
                        "Congo",
                        "Merck",
                        "vaccine",
                        "J&J",
                        "newcomer"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-22",
                "original_text": "Ex-Dividend Reminder: Atmos Energy, Johnson & Johnson and Newmark Group",
                "features": {
                    "keywords": [
                        "Ex-Dividend",
                        "Atmos Energy",
                        "Johnson & Johnson",
                        "Newmark Group"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy",
                        "healthcare",
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-22",
                "original_text": "Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "OBLN",
                        "CODX",
                        "AFMD",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-22",
                "original_text": "The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",
                "features": {
                    "keywords": [
                        "Daily Biotech Pulse",
                        "Tocagen",
                        "OncoSec",
                        "Novartis",
                        "Asthma",
                        "Combo Drug Study"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}